Common side effects include itching rash diarrhea shortness of breath pain redness inflammation itching at the injection site.
Copaxone side effects weight loss.
Our copaxone glatiramer acetate side effects drug center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
The information is not intended to cover all possible uses directions precautions drug interactions or adverse effects nor should it be construed to indicate that use of a particular drug is.
Check with your doctor immediately if any of the following side effects occur.
You may report side effects to fda at 1 800.
Some of the dosage forms listed on this page may not apply to the brand name copaxone.
Serious side effects may happen right after or within.
Learn about side effects warnings dosage and more.
This is not a complete list of side effects and others may occur.
Do not use copaxone if you are allergic to glatiramer acetate or mannitol.
This document contains side effect information about glatiramer.
Although not all of these side effects may occur if they do occur they may need medical attention.
Copaxone is a prescription medicine that is used to treat relapsing forms of multiple sclerosis ms to include clinically isolated syndrome relapsing remitting disease and active secondary progressive disease in adults.
Common side effects of copaxone include.
Went on copaxone way better have very few side effects don t worry about the injection site s just rotate all around your body i start at the hips belly and legs the copaxone people should give you a guide for mapping your injection site s take care and good luck you will be ok.
Hi there was on plergdy was not good for me bad side effects.
Glatiramer copaxone glatopa is a multiple sclerosis ms drug prescribed to treat individuals with relapsing multiple sclerosis ms.
Anxiety chest pain dyspnea lymphadenopathy palpitations post injection flare urticaria vasodilation flushing erythema at injection site induration at injection site.